MedImmune's P2P Acquisition

MedImmune raised a round of funding on April 23, 2007. Investors include AstraZeneca.

MedImmune develops and markets products that address medical needs in areas such as infectious disease, immune regulation and cancer.…

Articles about MedImmune's P2P Acquisition: